Loading insider details...
Beta
Latest Form 4 (Sep 2, 2026): Grant/Award of 21,750 ELTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 21,750 | n/a |
| May 29, 2026 | Immix Biopharma, Inc. (IMMX) | Grant/Award | 6,250 | n/a |
| Jun 23, 2025 | Immix Biopharma, Inc. (IMMX) | Grant/Award | 33,000 | n/a |
| Jun 4, 2025 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 103,225 | n/a |
| May 20, 2025 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 7,900 | n/a |
| Mar 7, 2025 | Elicio Therapeutics, Inc. (ELTX) | Conversion | 3,500,573 | $20.34M |
| Nov 25, 2024 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 4,100 | n/a |
| Aug 14, 2024 | Elicio Therapeutics, Inc. (ELTX) | Purchase | 3,442,341 | $20.00M |
| Jul 2, 2024 | Elicio Therapeutics, Inc. (ELTX) | Purchase | 1,600,000 | n/a |
| Jun 21, 2024 | Immix Biopharma, Inc. (IMMX) | Grant/Award | 33,000 | n/a |